People with Diabetes Archives

As 2025 comes to a close, it is clear that this has been a defining year for Glooko and for the broader evolution of diabetes care. Following the close of our Series F, we entered the year with a clear focus: deliver on our strategy, expand our global impact, and continue building technology that helps make diabetes care more connected, actionable, and human.

Accelerating our Mission through Strategic Leadership and a Connected Care Continuum

Over the past year, we reached several important milestones in support of that goal. We expanded our capabilities through the acquisition of Monarch Medical Technologies and its EndoTool Glucose Management System, bringing together complementary capabilities across outpatient and inpatient diabetes and glycemic management.

We strengthened our ecosystem with the launch of our Abbott FreeStyle Libre integration in the U.S., helping ensure that critical glucose data can flow more seamlessly to people with diabetes and their care teams.

We also reinforced our clinical leadership with the appointment of Mark Clements, M.D., Ph.D., as Chief Medical and Strategy Officer, underscoring our commitment to evidence-based innovation and strong clinical partnership.

Driving Digital Health Adoption in EMEA

We also saw meaningful traction across geographies and care settings.

In EMEA, we continued to expand our presence as health systems look for scalable, interoperable digital solutions to support diabetes care. At the same time, Glooko XT, our remote monitoring solution available only in France, introduced new features and strengthened its gestational diabetes management capability, an area where timely insights and coordinated care are critical for both maternal and fetal outcomes. These areas of momentum reflect the growing demand for digital tools that can support diverse patient populations and clinical workflows.

Further Enhancing our Diabetes Management Platform to Improve Care

On the product front, we continued to invest in tools designed for the realities of care delivery.

The launch of the new Glooko clinic dashboard marked an important step forward in helping clinics and health systems move beyond raw data to clearer insights, enabling more informed, timely decisions at the point of care. Across the organization, we remained focused on bringing teams together around a shared mission and shared standards, ensuring that our growth continues to be purposeful and aligned.

A reality faced by care teams each day is the need for timely, actionable data within existing clinical workflows. That’s why we invested further into our EHR capabilities this year and joined the Epic Showroom to make it easier for hospitals and health systems to seamlessly integrate their EHR with Glooko, helping reduce clinician burnout and optimize clinical workflows.

The Glooko Mobile App for people with diabetes also continued to innovate in 2025 with a redesigned food tracker for more insightful nutrition data and insights, revised insulin cards for more clarity, and viewable GLP-1 doses. These enhancements enable care teams to make more informed and timely treatment decisions between appointments using their patients’ health data – all viewable in one place.

How the U.S. Healthcare System is Moving Toward Data-Driven, Accountable Diabetes Care

These milestones matter, but they are occurring against a broader backdrop of change in healthcare that strongly validates this direction. The latest American Diabetes Association’s Standards of Care reinforce what clinicians and people with diabetes have long understood: technology-enabled management and data-driven insights are now foundational to delivering high-quality diabetes care.

At the same time, policy initiatives such as the CMS ACCESS program signal a growing emphasis on interoperability, data liquidity, and the responsible use of health data to improve outcomes at scale.

Together, these shifts point to a future in which diabetes care is increasingly proactive rather than reactive, and where data is not simply collected, but translated into meaningful action.

Regulatory momentum is reinforcing the importance of consistent, evidence-based glycemic management across care settings. CMS’s upcoming electronic clinical quality measure (eCQM) requirements for inpatient glycemic management, expected to take effect in 2026, reflect a growing emphasis on standardization, measurement, and accountability in hospital-based diabetes care. Solutions like EndoTool are at the forefront of this shift, helping health systems operationalize best practices, support clinical decision-making, and drive more reliable glycemic outcomes at scale.

For healthcare providers and care teams, this evolution brings both opportunity and urgency. As care becomes more continuous and data-rich, success depends on having tools, like Glooko’s EHR integrations, that reduce complexity, surface what matters most, and fit naturally into clinical workflows. The goal is not more data for its own sake, but clearer insight that supports better decisions and more personalized care.

For health systems, the focus is expanding to population-level impact. Managing chronic disease across diverse populations requires platforms that enable earlier intervention, more consistent care, and coordination across settings. Interoperable digital solutions, like Glooko, are becoming essential infrastructure for balancing quality, efficiency, and cost in an increasingly complex care environment.

Leveraging Scalable Healthcare Technology to Deliver Consistent Diabetes Care Around the World

Globally, the stakes are even higher. Diabetes prevalence continues to rise across regions with very different healthcare resources and delivery models. Scalable digital health solutions offer a path to extend evidence-based care, support clinicians, and bring greater consistency to diabetes management worldwide. As global standards and policies evolve, technology will play a central role in enabling more equitable access to high-quality care.

The Road Ahead for Glooko

Looking ahead, our focus at Glooko remains clear. We will continue investing in platforms that turn diabetes data into insight, insight into action, and action into better outcomes. We will deepen partnerships across the ecosystem and stay closely aligned with clinicians, health systems, and people with diabetes as their needs continue to evolve.

2025 was a year of momentum for Glooko. More importantly, it reinforced why our mission matters. As the future of diabetes care continues to take shape, we are energized by the opportunity to help lead the way.

EndoTool is developed and marketed by Monarch Medical Technologies, a Glooko Company. EndoTool is an FDA-cleared Class II medical device indicated for inpatient use as described in its Instructions for Use. Glooko’s diabetes management platform and EndoTool are currently independent solutions.

Through our ongoing commitment to enhancing diabetes care and simplifying diabetes management, we launched a redesigned food tracking experience in the Glooko Mobile App, making logging faster, more flexible, and even more insightful.

This powerful upgrade, featured in the Glooko Web App 25.3 and Mobile 6.13 release, is designed with the core purpose of making it easier for people with diabetes to log meals and for clinicians, endocrinologists, and the entire care team to streamline reviewing nutrition data alongside glucose trends, insulin doses, and exercise.

The new interface transforms the meal logging process, ensuring people with Type 1 diabetes, Type 2 diabetes, gestational diabetes, and prediabetes are more engaged with their nutrition tracking than ever before. For clinicians, the tool delivers the rich, contextual data needed for more impactful appointments and timely, data-backed interventions.

Ways for Easier and More Flexible Food Logging

The goal of the redesign was simple: make tracking food as quick and intuitive as possible for Glooko Mobile App users with diabetes. The new mobile experience allows users to:

Log Meals by Type: Start by simply selecting a meal type (breakfast, lunch, dinner, or snack).
Multiple Input Methods: Add food items instantly through a variety of convenient methods:
- Manual search of our expansive database of food items (Select languages only)
- Barcode scanning (U.S. only)
- Voice input (Select languages only)
- Quick add from our food database or through custom entry
Customize and Save Favorites: App users can now create custom food entries and easily mark meals or food items as favorites with a single tap of a heart for lightning-fast logging next time.
Review Before Saving: The ability to edit existing items for time, data, and serving size, or review the full meal with detailed nutritional summaries ensures accuracy before the data is saved.
View the Summary: A nutritional summary now appears after each logged meal to help users better understand their daily intake.

Providing Smarter Nutrition Insights and Visualizations

The new design goes beyond logging to provide users with a clearer picture of their diet composition:

Track Macro Distribution: The Glooko Mobile App now tracks the distribution of carbs, fat, and protein as a percentage of total calories per day. This vital feature helps users quickly assess if macro intake aligns with dietary goals and how it may be influencing glucose patterns.
Data-Packed Charts and Graphs: The simplified logging process means more consistent data, which is viewable in the Daily Log and a new Food Graph below the Carbs section of Charts and Graphs, allowing users to better understand diet-related glucose fluctuations and discuss potential changes with their care teams.
Enhanced Meal Visualization: Users and care teams can now view added meals directly in the History List of the Glooko web app, with each entry displaying the exact meal type, nutritional information, and details of the included food. This enhanced visualization provides a better understanding of how nutrition works together with insulin doses, exercise, medications, and weight. Previous views of carbs are still available in the Overview Graph, Daily Graph, Weekview, and Calendar.

A Comprehensive Approach to Diabetes Management

This revamped food tracking experience is more than just an update — it’s a powerful tool designed to foster better patient engagement and deliver insightful data people with diabetes and their healthcare providers need to manage diabetes more effectively.

With nutrition, exercise, medication, lifestyle management, and other health data, we’re creating a better way to manage diabetes. To get started, download the Glooko Mobile App on the App Store and the Google Play Store today.

*Not all product features are available in all countries.

Whether training for a marathon or curious about blood sugar trends when out on a neighborhood walk, tracking and uploading fitness and health data is easy with the Glooko Mobile App for people living with diabetes.

Bringing together exercise, health, and diabetes data from compatible diabetes and health monitoring devices and apps with Glooko enhances diabetes management and allows people with diabetes and their healthcare provider to have greater insight about what adjustments might need to be made in care plans. Having the data available in one place makes it easier for care teams to make more informed decisions about treatment moving forward.

As an added benefit, next time people living with diabetes won’t have to guess when their care team asks how many minutes of exercise they did in a week.

Glooko’s Compatibility with Health Monitoring and Fitness Devices and Apps

Our connected care platform is compatible with leading health monitoring and fitness devices and apps like Apple Health, activity trackers and smartwatches from Fitbit, Strava, Garmin, and blood pressure cuffs and scales from Withings. For select diabetes devices, Glooko can share glucose, CGM, and manually entered insulin data in Glooko with Apple Health. Glooko Mobile App users also have the ability to manually track physical activity by selecting a variety of sports and exercises built into the platform and note the duration, calories burned, and intensity (light, medium, and hard).

When coupling these apps and manual entry of exercise history with the glucose, insulin, and the nutrition tracking capabilities of Glooko, the physical activity data provides care teams the ability to craft more personalized treatment plans and to see how different activities affect levels.

Once this helpful exercise data is imported into Glooko through a sync or manually,it can be found in a variety of our Glooko platforms, including Summary, Graphs, and History, depending on the data. This section provides key information such as step count, number of exercises, and duration of exercise alongside key data points healthcare providers use to make recommendations about insulin and other medication changes. The data displayed will automatically adjust to reflect the selected date range with visualizations changing based on the type of data.

Syncing Lifestyle Management Data with Glooko

Glooko also supports blood pressure and weight data from compatible blood pressure cuffs and scales from Withings. Bluetooth- and cloud-enabled devices automatically sync with Glooko while readings from non-Bluetooth devices must be manually entered in the Glooko Mobile App to be viewed alongside other health data.

Unlock Deeper Insights by Sharing Health Data with Care Teams

To share data from compatible fitness and health monitoring devices and apps with care teams or use it as a reference, simply ensure the ProConnect Code used by the healthcare team is added. To do this, select “Care Teams” from the home screen, then “+ Care Team,” and enter the designated ProConnect Code using all lowercase letters.

From the Glooko Mobile App home screen, select “Sync Device” then “Add New Device,” which will prompt the user to select a category of devices to add. On this screen, select “Fitness and Health Devices” to search for compatible devices or apps to connect.

Once the data is synced, it will be shared with the user’s healthcare provider remotely and at the next appointment alongside blood sugar, insulin, and other diabetes data. The healthcare provider will have the advantage of seeing how exercise may be impacting glucose levels and will be better prepared for conversations about any insulin dosing adjustments that should be considered.

Time to Upload Exercise and Lifestyle Management Data to Glooko

Visit our Support Center for help with syncing fitness and health monitoring devices and apps with Glooko.

*Not all product features are available in all countries.

Today marks an important milestone in our mission to transform diabetes care. I am excited to share that Glooko has acquired Monarch Medical Technologies, creators of the EndoTool® Glucose Management System.

With this acquisition, Glooko is positioned to become the only diabetes management company with the potential to connect the full continuum of care — from home to hospital and back again. By bringing together EndoTool’s proven inpatient insulin dosing technology with Glooko’s leading outpatient platform, we aim to create a future where care is seamless, safer, and more supportive for both people living with diabetes and healthcare providers.

For patients, this means fewer disruptions as they move between settings, reduced risk of dangerous glycemic events, and more confidence that their care is connected. For healthcare providers, it means access to tools that simplify complex insulin management, standardize protocols, and free up time to focus on what matters most, which is caring for people.

This step also sets the foundation for Glooko’s future: using data and AI to help clinicians anticipate risks earlier, personalize care at scale, and improve outcomes under value-based models. By aligning advanced technology with clinical guidelines and EHR workflows, we can help hospitals and health systems deliver higher-quality care while lowering costs.

Our mission has always been clear: to simplify diabetes management, strengthen connections across the care team, and improve lives. This acquisition represents an important stride toward that vision.

Together, we are building a future where diabetes care is more connected, proactive, and patient-centered than ever.

We’re excited to announce the latest updates to Glooko Web 25.2 and Mobile 6.12, which are designed to help healthcare providers and people with diabetes by streamlining workflows, providing a new population management dashboard to triage at-risk patients and review population-level metrics, improving data visualizations, and giving care teams more powerful data from compatible devices to enhance diabetes management.

Introducing the New Clinic Dashboard

In this release, we launched a new clinic dashboard in the U.S. designed to give healthcare professionals at-a-glance insights into population health trends and clinic management metrics. This enhancement makes it easier to interpret complex data and guide decisions and clinic strategy more efficiently across care teams.

Other new clinic dashboard highlights include:

Population Metrics: This section gives a single, concise, and organized view of the clinic’s total patient population, patients monitoring blood glucose, and those with activated accounts using key engagement and monitoring metrics.
CGM Patient Risk Stratification: This dashboard, modeled after the Timely Interventions for Diabetes Excellence (TIDE) Dashboard, gives healthcare providers a streamlined view of their patient population, ranked by risk level using key glucose metrics and CGM data only. Care teams can identify risk levels using Time in Range, Time Below Range, and other key CGM indicators to prioritize care.
Engagement Metrics: This section helps healthcare providers spot engagement gaps within their patient population over the past 90 days and take action to get more patients connected and syncing their devices with Glooko. With more synced health data, care teams can make more informed treatment decisions.

Banner Notification for Missing MRN

Glooko’s connected care platform prioritizes deep EHR integration to bring actionable diabetes data into the systems clinicians already use. To help maintain EHR data integrity and ensure patient matching is seamless, Glooko introduced a clear dismissible banner on the patient dashboard to notify clinicians when a Medical Record Number (MRN) is required but missing.

Tandem Basal Profile Switches

A new icon in DayView and WeekView on the Glooko diabetes management platform identifies when a patient changes their Tandem Personal Profile to give better context for insulin delivery.

GLP-1 Dose Enhancements

GLP-1 doses will now be displayed in the Glooko Web and Mobile software with improved messaging and clinical disclaimers. Healthcare professionals will now receive relevant dose range notifications while also providing precise dose information to support better oversight and patient adherence, while patients will see exact GLP-1 doses up to two decimal places as injected.

Device Type Display in PDFs

Glooko will now display controller device types in the PDF Settings Report, helping clinicians more clearly understand where data originated for users of Omnipod® 5 and other select devices. The report will specifically say on a clear device label the upload method (e.g., Android, iOS, Locked Down Controller) used by the patient.

Updated Insulin Statistics Design

The Glooko Mobile App’s insulin card has been redesigned to enhance clarity and consistency, particularly benefiting users with insulin pump data. This update aims to improve the understanding of insulin averages and minimize confusion between pump and total insulin values by displaying data in one unified insulin card.

More Information on the Latest Glooko Release

For more detailed information about these new features intended to enhance clinical practices and transform diabetes, be sure to check the full release notes on our Glooko Support page.

The NHS’s ambitious “Fit for the Future: 10 Year Health Plan for England” outlines a bold vision for the future of healthcare in the country — one that is digitally advanced, community-focused, and prevention-driven. It’s a plan designed to move healthcare from a reactive, hospital-centric model to a proactive, patient-empowering system utilising cutting-edge technologies. Within this transformative agenda, Glooko’s diabetes management platform stands out as an excellent example of how digital health solutions can directly support these crucial goals.

From Analogue to Digital: Empowering Patients and Streamlining Care

At the heart of the NHS’s plan is a commitment to becoming «digital by default.» This means harnessing technology to make healthcare more accessible, efficient, and patient-friendly.

Imagine a world where your health data, whether from your BGM, CGM, insulin pen, or activity tracker, is all in one place. That’s what Glooko offers through its integrations with more than 200 diabetes and health monitoring devices, including wearables, a future standard in the NHS by 2035. By centralising this vital information, it empowers people living with diabetes to take a more active role in managing their diabetes and saves them time by not having to juggle multiple apps or manually record readings.

For healthcare professionals, Glooko centralises health data from their patients into a single platform, helping create the «single, secure and authoritative account of their data» that the NHS aims for. To help reduce time-wasting administrative tasks, streamline workflows, and allow clinicians to have more efficient appointments focused on providing quality care, Glooko is expanding its capability to sync with electronic health record (EHR) systems across England and the rest of Europe. When all the relevant data is at their fingertips and seamlessly flowing between clinical records and the Glooko platform, everyone on the care team, including diabetologists, diabetes specialist nurses, registered dietitians, and general practitioners, can make more informed clinical decisions using our diabetes technology.

With our commitment to safeguarding confidential personal information and handling patient data properly, our diabetes management platform and our company’s practices meet the NHS’s data security standards outlined in the Data Security and Protection Toolkit. We align with the NHS’s requirements for all organisations with access to their patient data and systems.

From Hospital to Community: Enabling Remote Monitoring and Personalised Care

The NHS plan emphasises shifting care away from hospitals and into local communities and even patients’ homes. Glooko is instrumental in making this a reality for diabetes care with its remote patient monitoring capabilities.

This innovative feature of our diabetes software for healthcare providers means fewer trips to the hospital for routine check-ups and more proactive management of diabetes from the comfort of a patient’s home. This not only improves convenience for people living with diabetes but also helps to alleviate pressure on acute hospital services and supports the development of community-based models like «Neighbourhood Health Centres.”

The Glooko connected care platform offers powerful population health analytics. This allows hospitals to view trends and manage their entire patient population more effectively, aligning with the NHS’s goal of preventing illness and managing long-term conditions on a larger scale. The detailed insights provided by Glooko’s data can also support the creation and monitoring of highly personalised care plans, moving closer to the NHS’s goal of offering personal health budgets and tailored support for complex needs like diabetes.

From Sickness to Prevention: Proactive Management and Improved Outcomes

A core tenet of the NHS’s 10 Year Health Plan is a strong focus on prevention and early intervention.

By providing continuous diabetes and related health data and insights, Glooko helps healthcare providers identify potential issues and risks before they escalate. This allows for proactive intervention, which can significantly reduce the likelihood of diabetes-related complications, improving long-term health for patients.

And Glooko isn’t just about data; it’s about demonstrable results. The diabetes management platform has a track record of improving clinical outcomes, including reduced HbA1c levels. These outcomes directly align with the NHS’s aspirations for better health for the population, reduced demand on acute services, and a more sustainable healthcare system.

A Healthier Future for People with Diabetes

We want the NHS 10 Year Health Plan to deliver real improvements for people with diabetes and their care teams. Glooko is more than a diabetes management tool; we’re a strategic partner committed to helping the NHS deliver better care for all patients regardless of wherever they live and whatever they earn.

By accelerating digital transformation, enabling care at home, and championing proactive diabetes management, Glooko is helping build a more efficient, patient-centered, and digitally advanced healthcare system.

With innovative solutions and preferred vendors like Glooko, the NHS is well-equipped to meet the challenges and opportunities ahead as they usher in the future of healthcare in England.

Managing diabetes care has become increasingly complex for clinics, hospitals, and health systems. With a growing number of people living with diabetes relying on multiple devices — glucose meters, continuous glucose monitors (CGMs), insulin pumps, and wearables — healthcare providers face the challenge of piecing together critical data from siloed systems. This fragmentation not only consumes valuable time, but hinders patient care.

At Glooko, we know device integration is the key to solving these challenges and transforming diabetes management. As a market leader in device compatibility, EHR integration, and interoperability, Glooko increases efficiency of clinical workflows by streamlining administrative tasks, enhances patient engagement, and helps deliver better outcomes.

The Challenges of Fragmented Diabetes Management

For healthcare providers, piecing together data from various devices and platforms and apps can feel like an endless puzzle. Without device integrations, clinics and health systems face:

Disconnected Data: Patient data is scattered across incompatible platforms and apps, making it difficult to understand a patient’s holistic health.
Inefficient Workflows: Healthcare providers must spend time manually entering or retrieving data instead of focusing their time and expertise to support their patients in achieving better health.
Limited Patient Engagement: Patients often struggle to track their progress with so many different tools and apps, becoming overwhelmed and losing hope in their ability to make meaningful change.

These challenges contribute to missed opportunities for timely interventions that drive better health outcomes.

How Glooko’s Compatibility Brings Clarity to Diabetes Care

Glooko simplifies diabetes management by integrating data from more than 200 diabetes and health monitoring devices — including Abbott’s FreeStyle Libre CGMs in the U.S. — into a single, user-friendly platform.

Here’s how Glooko’s device compatibility transforms care:

Data Integration and Interoperability: Glooko consolidates glucose levels, insulin usage, and lifestyle behaviors such as diet and physical activity, giving healthcare providers a holistic view of patient health. Care teams can easily access patient data from a centralized platform.
Remote Monitoring Capabilities: Healthcare providers can track patient trends and progress between visits, ensuring timely adjustments to care plans and reducing unnecessary appointments and emergency room visits.

Not all devices are available in every country where Glooko is available. The product images are for illustrative purposes only. Not actual patient data. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission. Important Safety Information: For full FreeStyle Libre systems safety information, please visit https://www.freestyle.abbott/us-en/safety-information.html.

The Many Benefits of Integration for Clinics, Hospitals, and Health Systems

Our industry-leading device compatibility benefits clinics, hospitals, and health systems by streamlining workflows and improving decision-making through a comprehensive view of patient data. With greater efficiency, care teams can focus more on patient care and expand their reach to serve more individuals in need.

Streamlined Workflows: Staff spend less time on administrative tasks and more time on what they do best: educating and providing care to their patients.
Improved Decision-Making: A comprehensive view of patient data allows care teams to create more personalized and effective treatment plans.
Expanded Clinical Footprint: With more time, clinicians can help more patients in need.

To enable more meaningful data insights, Glooko also seamlessly integrates the health data from their patients’ diabetes and health monitoring devices directly into leading EHR systems, eliminating manual uploads and platform switching and reducing administrative burden.

The Key Benefits of Device Integrations for People Living with Diabetes

Glooko’s device integrations benefit people living with diabetes by simplifying their experience and empowering self-management through centralized data, reducing app overload and supporting informed health decisions.

Simplified Experience: With integrated data, patients no longer need to juggle multiple apps and passwords, or manually report their glucose levels to their provider.
Empowered Self-Management: Patients can log meals, exercise, and medications directly in the Glooko app, helping them understand how their choices impact their health.

Proven Results Backed by Global Expertise

Glooko has more than a decade of experience integrating diabetes and health monitoring devices worldwide, supporting millions of people living with diabetes. Glooko’s connected care platform, backed by real-world evidence, delivers the reliability, scalability, and insights clinics, hospitals, and health systems need to stay ahead in diabetes care, setting a new standard.

Simplify Diabetes Care with Glooko

The complexity of diabetes management doesn’t have to hold your clinic, hospital, or health system back. By choosing Glooko, you can eliminate data fragmentation, enhance patient care, and create a more efficient, streamlined experience for healthcare providers and people living with diabetes.

Schedule a personalized demo of our digital health platform today and see how your patients’ health data can be integrated directly into your EHR system.

As a leader in diabetes management, Glooko offers an intelligent connected care platform that allow people with diabetes and their healthcare providers to review, analyze, and evaluate data from many different types of diabetes devices, including blood glucose meters (BGM), continuous glucose monitoring (CGM) systems, insulin pumps, smart pens, and fitness apps.

With Glooko’s digital health solution allowing users to view and analyze CGM and insulin data in one place, we have the ability to work with hybrid closed loop systems, a technology — often known as an artificial pancreas — that automates many of the daily decisions of people living with Type 1 diabetes who use an insulin pump and CGM that communicate with each other.

Innovative hybrid closed loop systems take readings from an individual’s CGM and use an algorithm to automatically tell the insulin pump how much insulin to deliver to keep blood glucose levels stable around the clock.

How Glooko integrates with hybrid closed loop systems

Our digital health platform, used by over 10,000 clinics in more than 30 countries, syncs via the cloud with leading diabetes CGMs and insulin pumps in hybrid closed loop systems to automatically present data around glucose levels, basal rates and more to patients and their care teams via graphically-oriented reports that can help recognize trends, so they can take action to improve their health outcomes.

The hybrid closed loop systems that currently sync with Glooko include:

Depending on the brands of the insulin pump and CGM, different methods of syncing via cloud are required to view data in Glooko from hybrid closed loop systems.

Glooko and Hybrid Closed Loop Systems for Diabetes — **Method 1**

Like any great technology, people living with diabetes using a closed loop system still must check to ensure it is working and must count carbohydrates to give the system the correct bolusing data before food consumption. This is where the Glooko Mobile App’s food tracker can be used to track nutrition by searching the food database, using voice capture, or scanning a barcode (in select countries).

Benefits of using hybrid closed loop systems with Glooko

There are many benefits of using hybrid closed loop systems alongside Glooko for patients, including:

Major changes in treatment that reduce daily burdens and mental stress
More time with glucose levels in range with less effort
The ability to visualize blood glucose and insulin data in clear graphs that make it easier to understand automatic boluses and basal rates

There are also many benefits of using hybrid closed loop systems alongside Glooko for care teams, including:

An increased monitoring of patients with diabetes who are using closed loop systems
Strengthening their connection with their patients
Better management of fluctuations in patients’ glucose levels
Easier interpretation of patient data around basal rate, automatic vs. manual mode and automatic boluses

The future of hybrid closed loop systems

Hybrid closed loop systems in diabetes care are advancing toward more automation, intelligence, and accessibility. These systems are on a path toward becoming fully closed loop systems that will make managing diabetes more automated, adaptive, and accessible, allowing users to focus less on their condition and more on living life.

As the systems evolve, so will Glooko. With the regular introduction of new hybrid closed loop systems, Glooko will continue to partner with leading device manufacturers to integrate their platforms with our digital health solution.

For more information about using a hybrid closed loop system, consult with your healthcare team and explore resources from the Breakthrough T1D, Diabetes UK, and NHS England.

The Glooko 2025 Global Diabetes Report offers a comprehensive look at how real-world data can drive better outcomes in diabetes care. Powered by billions of data points across 30+ countries, this report uncovers meaningful trends in glycemic management, technology adoption, and behaviors among people living with Type 1, Type 2, and gestational diabetes.

From the rise of remote monitoring to the impact of advanced technologies like Continuous Glucose Monitors (CGMs) and Automated Insulin Delivery (AID) systems, this report explores how personalized insights can be used to better inform personalized care, predict risk, and guide clinical decision-making.

Whether you’re a clinician, researcher, or innovator in diabetes management technology, this report highlights how data can be turned into action — helping to shape a smarter, more connected future of diabetes management.

Download the report

At Glooko, we are committed to simplifying diabetes insights and management for people living with diabetes and healthcare providers alike. That’s why our platform is compatible with more than 200 diabetes and health monitoring devices and growing.

As a company, we could not be more pleased to share that we recently expanded our capabilities to integrate with Abbott’s FreeStyle Libre CGMs in the United States. This integration brings glucose data to more clinics and health systems in our all-in-one solution for diabetes management.

This milestone is more than just a technological advancement — it’s about empowering people with Type 1, Type 2, and gestational diabetes, as well as prediabetes, to become active owners in their health. By combining the precision of Abbott’s FreeStyle Libre CGMs with Glooko’s comprehensive platform, we can provide people living with diabetes and their care teams, including endocrinologists and nurses, with a unified, holistic view of diabetes management and irrefutable information.

From glucose trends to lifestyle behaviors like diet and physical activity, this latest integration ensures that critical insights are easily accessible when and where they are needed most. For healthcare providers and health systems, this means the ability to seamlessly access and analyze patients’ CGM data through Glooko and established electronic health record (EHR) solutions, more informed decision-making, and improved patient outcomes. For people living with diabetes, it means greater confidence in their care and health.

As the number of people with diabetes continues to grow, the need for seamless, data-driven solutions has never been greater. Our new integration with Abbott’s FreeStyle Libre CGMs represents a significant step forward in delivering better, more connected care. This partnership is sure to have a positive impact on the millions of people who rely on FreeStyle Libre CGMs and Glooko.